Table 2

Residual reactivities of the allodepleted CD137/65neg cell subsets compared with undepleted control-cell populations

Median, %Range, %Donor/recipient pairs, n
Antimismatch HLA* 9.5 1-16 15 
Antileukemia/tumor* 58 36-92 10 
Anti-CMV/EBV† 78 24-150 7 
Median, %Range, %Donor/recipient pairs, n
Antimismatch HLA* 9.5 1-16 15 
Antileukemia/tumor* 58 36-92 10 
Anti-CMV/EBV† 78 24-150 7 
*

IFN-γ ELISPOT results obtained from day 22 T-cell cultures.

†

IFN-γ ELISPOT and HLA tetramer results obtained from day 22 T-cell cultures.

View Large